Opioid litigation

Confronting the opioid epidemic

Opioid Litigation

Utah’s opioid litigation began as a response to the overdoses and deaths that have pained our communities across the state. Families struggled with addiction, emergency services were stretched thin, and local governments absorbed escalating costs tied to treatment, law enforcement, and child welfare. Utah’s legal action was grounded in a simple principle: those who helped create a public health crisis must be held accountable and help abate future harm. 

The Office of the Attorney General, working in coordination with the Utah Department of Commerce’s Division of Consumer Protection and under the leadership of Governor Spencer Cox, has filed lawsuits against opioid manufacturers, distributors, and marketers.  

As evidence mounted nationwide, Utah joined multistate efforts to confront opioid manufacturers and their owners, including Purdue Pharma and the Sackler family. The litigation has shown that Utah’s local harms were connected to a broader pattern of deceptive marketing, oversupply, and a disregard for addiction risks that fueled widespread opioid dependence, diversion, and abuse. 

The cases expanded over time to include manufacturers, distributors, pharmacy chains, marketing consultants, and pharmacy benefit managers, reflecting the full scope of the opioid supply chain.  

Landmark national settlements ultimately brought billions of dollars in relief. Utah’s share—distributed over many years—represented both accountability and a long-term commitment to stopping and abating the damage caused by opioids across the state. 

Together, these cases mark a shift in how Utah confronts complex public health crises through the legal system. The timeline that follows traces the state’s path from early litigation to historic settlements—and the lasting impact of those efforts on Utah communities. 

Opioid litigation Timeline

May 31, 2018: Utah Sues Purdue Pharma

The Office of the Attorney General filed a lawsuit against Purdue Pharma alleging that the company fueled the opioid crisis by downplaying the addictiveness of its drug OxyContin. This complaint was filed in Carbon County, which was particularly harmed by the opioid epidemic.

January 30, 2019: Utah Files administrative action against purdue pharma and the sackler family

The Utah Division of Consumer Protection, represented by the Office of the Attorney General, filed an administrative enforcement action against Purdue Pharma and individual members of the Sackler family. The action alleged violations of the Utah Consumer Sales Practices Act for misleading marketing and misrepresentations about the addictiveness and safety of opioid drugs.

July 21, 2021: Utah joins $26 billion national settlement with three pharmaceutical companies

Utah joined a landmark $26 billion national opioid settlement with the nation’s three largest pharmaceutical distributors—McKesson, Cardinal Health, and AmerisourceBergen—and Johnson & Johnson. The Office of the Utah Attorney General alleged that distributors failed to maintain effective controls against opioid diversion and that Johnson & Johnson improperly promoted opioid products. Utah’s participation resolved its claims against these defendants and secured long-term funding for opioid abatement.

Spring 2024: Utah enters consent judgments with teva and walgreens

Utah entered consent judgments resolving opioid claims against Teva Pharmaceuticals and Walgreens. The settlements alleged that Teva substantially contributed to opioid oversupply and Walgreens failed to properly monitor and prevent suspicious opioid dispensing at its pharmacies.

March 4, 2024: Utah enters consent judgment with cvs

Utah entered a consent judgment with CVS, resolving allegations that the pharmacy chain filled excessive opioid prescriptions despite clear warning signs of abuse and diversion.

March 11, 2024: Utah enters consent judgment with walmart

Utah entered a consent judgment with Walmart, resolving claims that the company’s pharmacies contributed to opioid misuse by failing to implement adequate safeguards against improper dispensing.

December 23, 2024: Utah files lawsuit against pharmacy benefit managers

The Office of the Utah Attorney General and the Utah Division of Consumer Protection filed a lawsuit against two major pharmacy benefit managers, including entities affiliated with UnitedHealth Group/Optum and Express Scripts. The complaint alleged that PBMs helped drive opioid harm by distorting prescribing incentives and prioritizing profits over patient safety.

June 17, 2025: Utah settles with Purdue Pharma

Utah joined a nationwide $7.4 billion settlement with Purdue Pharma and the Sackler family, resolving the state’s remaining claims against the company and its owners.